Phlotonics Receives $1.1M Award to Adapt BioproSense™ Platform for Regenerative Medicine

“These collaborations not only leverage the specialized scientific expertise of university research teams, but also play a vital role in supporting regional startup ecosystems by anchoring cutting-edge R&D in local innovation hubs.”

Collaboration through AIM Photonics’ BioINSPECT program—a joint initiative between AIM Photonics and Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA—is helping drive new advances in regenerative medicine.

Under the program, AIM Photonics member Phlotonics Inc. has been awarded a $1.1M contract to work with leading academic researchers from the University of Rochester and Rochester Institute of Technology to adapt its BioproSense™ platform for regenerative biomanufacturing.

This effort reflects the strategic value of public-private partnerships and regional collaboration, bringing together industry, universities and federally funded programs to accelerate biomanufacturing breakthroughs.

Read the full article on pholotonics.com